EFFECTS OF PIOGLITAZONE ON HEPATIC AND PERIPHERAL INSULIN RESISTANCE IN WISTAR FATTY RATS

被引：0
|
作者：
SUGIYAMA, Y
SHIMURA, Y
IKEDA, H
机构：
来源：
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1990年 / 40-1卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：436 / 440
页数：5
相关论文
共 50 条
  • [41] EFFECTS OF PIOGLITAZONE THERAPY ON HEPATIC FATTY ACID SYNTHESIS, BETA-OXIDATION AND HEPATIC STELLATE CELLS: IS THE DRUG MORE THAN AN INSULIN SENSITIZER?
    Rahim, Roslina Abdul
    Kaye, Philip
    Macdonald, Ian A.
    Bennett, Andrew J.
    Aithal, Guruprasad P.
    HEPATOLOGY, 2009, 50 (04) : 763A - 764A
  • [42] The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog
    Sindelar, DK
    Chu, CA
    Rohlie, M
    Neal, DW
    Swift, LL
    Cherrington, AD
    DIABETES, 1997, 46 (02) : 187 - 196
  • [43] THE ROLE OF FATTY-ACIDS IN MEDIATING THE EFFECTS OF PERIPHERAL INSULIN ON HEPATIC GLUCOSE-PRODUCTION
    SINDELAR, D
    CHU, C
    HASTINGS, J
    VENSON, P
    CHERRINGTON, A
    DIABETES, 1995, 44 : A55 - A55
  • [44] Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity
    Yarasheski, Kevin E.
    Cade, W. Todd
    Overton, E. Turner
    Mondy, Kristin E.
    Hubert, Sara
    Laciny, Erin
    Bopp, Coco
    Lassa-Claxton, Sherry
    Reeds, Dominic N.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (01): : E243 - E251
  • [45] PIOGLITAZONE AMELIORATES FRUCTOSE-INDUCED DEFECTS IN VLDL-TRIGLYCERIDE CATABOLISM IN WISTAR FATTY RATS
    KAZUMI, T
    HIRANO, T
    YOSHINO, G
    DIABETES, 1994, 43 : A38 - A38
  • [46] Hepatic Insulin Resistance Model in the Male Wistar Rat Using Exogenous Insulin Glargine Administration
    Sarmiento-Ortega, Victor Enrique
    Moroni-Gonzalez, Diana
    Diaz, Alfonso
    Garcia-Gonzalez, Miguel Angel
    Brambila, Eduardo
    Trevino, Samuel
    METABOLITES, 2023, 13 (04)
  • [47] Influence of the pharmacokinetic profile on the plasma glucose lowering effect of the PPAR agonist pioglitazone in Wistar fatty rats
    Goto, Akihiko
    Tagawa, Yoshihiko
    Kimura, Yoshiaki
    Kogame, Akifumi
    Moriya, Yuu
    Amano, Nobuyuki
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (06) : 381 - 388
  • [48] Effects of Dietary n-3 Fatty Acids on Hepatic and Peripheral Insulin Sensitivity in Insulin-Resistant Humans
    Lalia, Antigoni Z.
    Johnson, Matthew L.
    Jensen, Michael D.
    Hames, Kazanna C.
    Port, John D.
    Lanza, Ian R.
    DIABETES CARE, 2015, 38 (07) : 1228 - 1237
  • [49] IS HEPATIC INSULIN-RESISTANCE A MAJOR FEATURE OF NIDDM PATIENTS WITH PERIPHERAL INSULIN-RESISTANCE
    STAEHR, P
    HOTHERNIELSEN, O
    LEVIN, K
    BECKNIELSEN, H
    DIABETOLOGIA, 1994, 37 : A136 - A136
  • [50] Less of insulin desensitization in sympathetic nerve terminals from Wistar rats with insulin resistance
    Chi, TC
    Liu, IM
    Cheng, JT
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 2000, 80 (1-2): : 80 - 84
12345